<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">9918486684106676</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">52023</journal-id>
      <journal-id journal-id-type="nlm-ta">Dystonia</journal-id>
      <journal-id journal-id-type="iso-abbrev">Dystonia</journal-id>
      <journal-title-group>
        <journal-title>Dystonia (Lausanne, Switzerland)</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2813-2106</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">39262575</article-id>
      <article-id pub-id-type="pmc">11390104</article-id>
      <article-id pub-id-type="doi">10.3389/dyst.2024.12016</article-id>
      <article-id pub-id-type="manuscript">NIHMS1982898</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic toggle="yes">REEP4</italic> variant analysis in blepharospasm and other neurological disorders</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Saeirad</surname>
            <given-names>Samira</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>LeDoux</surname>
            <given-names>Mark S.</given-names>
          </name>
          <xref rid="A1" ref-type="aff">1</xref>
          <xref rid="A2" ref-type="aff">2</xref>
          <xref rid="CR1" ref-type="corresp">*</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>Department of Psychology, University of Memphis, Memphis, TN, United States</aff>
      <aff id="A2"><label>2</label>Veracity Neuroscience LLC, Memphis, TN, United States</aff>
      <author-notes>
        <fn fn-type="con" id="FN1">
          <p id="P1">Author contributions</p>
          <p id="P2">ML obtained funding, designed the experiments, analyzed data and wrote the manuscript. SS performed the experiments, analyzed data and wrote the manuscript. Both authors contributed to the article and approved the submitted version.</p>
        </fn>
        <corresp id="CR1"><label>*</label><bold>CORRESPONDENCE</bold> &#x2709; Mark S. LeDoux, <email>mledoux@veracityneuroscience.com</email></corresp>
      </author-notes>
      <pub-date pub-type="nihms-submitted">
        <day>19</day>
        <month>4</month>
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>07</day>
        <month>2</month>
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>11</day>
        <month>9</month>
        <year>2024</year>
      </pub-date>
      <volume>3</volume>
      <elocation-id>12016</elocation-id>
      <permissions>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract id="ABS1">
        <sec id="S1">
          <title>Introduction:</title>
          <p id="P3">In preceding work, a deleterious <italic toggle="yes">REEP4</italic> variant [GRCh38/hg38, NC_000008.11:g.22140245G&gt;A, NM_025232.4:c.109C&gt;T, p.Arg37Trp] was found to co-segregate with blepharospasm (BSP) in a large African-American pedigree. Other <italic toggle="yes">REEP4</italic> variants have been reported in genetic screening studies of dystonia. The <italic toggle="yes">REEP4</italic> paralogs, <italic toggle="yes">REEP1</italic> and <italic toggle="yes">REEP2,</italic> are associated with spastic paraplegia. The causal contributions of <italic toggle="yes">REEP4</italic> variants to dystonia and other neurological disorders remains indecisive.</p>
        </sec>
        <sec id="S2">
          <title>Methods:</title>
          <p id="P4">Sanger sequencing was used to screen subjects (<italic toggle="yes">N</italic> = 307) with BSP and BSP-plus dystonia affecting additional anatomical segments (BSP+) phenotypes for variants in <italic toggle="yes">REEP4. In silico</italic> tools were used to examine the deleteriousness of reported (ClinVar) and previously published <italic toggle="yes">REEP4</italic> variants.</p>
        </sec>
        <sec id="S3">
          <title>Results:</title>
          <p id="P5">No highly deleterious variant was identified in coding or contiguous splice site regions of <italic toggle="yes">REEP4</italic> in our cohort of 307 subjects. <italic toggle="yes">In silico</italic> analysis identified numerous deleterious <italic toggle="yes">REEP4</italic> variants in published screening studies of dystonia and several highly deleterious single nucleotide <italic toggle="yes">REEP4</italic> variants in ClinVar.</p>
        </sec>
        <sec id="S4">
          <title>Conclusion:</title>
          <p id="P6">Highly deleterious <italic toggle="yes">REEP4</italic> variants are rare in BSP and BSP+ phenotypes.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>blepharospasm</kwd>
        <kwd>
          <italic toggle="yes">REEP4</italic>
        </kwd>
        <kwd>Sanger sequencing</kwd>
        <kwd>genetic variant</kwd>
        <kwd>dystonia</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="S5">
      <title>Introduction</title>
      <p id="P7">Blepharospasm (BSP) is a focal dystonia characterized by involuntary orbicularis oculi spasms that are usually bilateral, synchronous, and symmetrical [<xref rid="R1" ref-type="bibr">1</xref>]. BSP typically spreads to nearby craniocervical segments, including the lower face, masticatory muscles, and neck, resulting in segmental craniocervical dystonia [<xref rid="R2" ref-type="bibr">2</xref>, <xref rid="R3" ref-type="bibr">3</xref>]. The term BSP-plus (BSP+) is used to describe individuals with BSP who experience further spread to additional anatomical segments [<xref rid="R2" ref-type="bibr">2</xref>&#x2013;<xref rid="R4" ref-type="bibr">4</xref>].</p>
      <p id="P8">A notable percentage of BSP probands have at least one 1st-degree relative with dystonia [<xref rid="R5" ref-type="bibr">5</xref>&#x2013;<xref rid="R8" ref-type="bibr">8</xref>]. Defazio and co-workers [<xref rid="R8" ref-type="bibr">8</xref>] examined 233 relatives of 56 probands with isolated BSP and found a 1st-degree relative affected by BSP or other anatomical distribution of dystonia in 27%. Penetrance is approximately 20% in pedigrees with BSP [<xref rid="R8" ref-type="bibr">8</xref>, <xref rid="R9" ref-type="bibr">9</xref>]. For comparison, penetrance of the classic &#x394;GAG mutation in <italic toggle="yes">TOR1A</italic> (DYT1) is 30%&#x2013;40% [<xref rid="R10" ref-type="bibr">10</xref>]. Approximately 10% of subjects in published biorepositories of isolated dystonia report a relative with dystonia [<xref rid="R11" ref-type="bibr">11</xref>&#x2013;<xref rid="R15" ref-type="bibr">15</xref>].</p>
      <p id="P9">Even though late-onset isolated dystonias including BSP and BSP+ have a notable heritable component, large pedigrees adequately powered for linkage analysis are rare. Although rare cases of isolated BSP have been linked to <italic toggle="yes">THAP1</italic> mutations [<xref rid="R16" ref-type="bibr">16</xref>], the genetic underpinnings of this important focal dystonia remained largely unknown until identification of a deleterious co-segregating <italic toggle="yes">REEP4</italic> variant [GRCh38/hg38, NC_000008.11:g.22140245G&gt; A, NM_025232.4:c.109C&gt;T, p.Arg37Trp] in seven subjects with BSP or BSP+ from a 3-generation African-American BSP/BSP+ pedigree [<xref rid="R17" ref-type="bibr">17</xref>]. Follow-up screenings of large cohorts of patients with BSP and other forms of dystonia for <italic toggle="yes">REEP4</italic> variants is a logical and necessary next step in the study of BSP [<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref>]. Additional <italic toggle="yes">REEP4</italic> variants have been identified in single cases of BSP, but to our knowledge, no other highly deleterious and co-segregating variants have been reported in other multiplex pedigrees.</p>
      <p id="P10">REEP4, a member of the receptor expression-enhancing protein (REEP) family, contributes to nuclear pore formation [<xref rid="R20" ref-type="bibr">20</xref>]. Other dystonia-associated genes <italic toggle="yes">(TOR1A</italic> and <italic toggle="yes">NUP62)</italic> play critical roles in nuclear pore functions including nucleocytoplasmic trafficking [<xref rid="R21" ref-type="bibr">21</xref>, <xref rid="R22" ref-type="bibr">22</xref>]. Spastic paraplegia (SPG) has been linked to mutations in other family members (REEP1/SPG31 and REEP2/SPG72). Although not yet reported in SGP31 and SPG72, dystonia is a phenotypic feature of many SPGs [<xref rid="R23" ref-type="bibr">23</xref>]. In aggregate, existing genetic, cellular, and clinical data suggest that <italic toggle="yes">REEP4</italic> is a candidate gene for dystonia and other neurological disorders.</p>
    </sec>
    <sec id="S6">
      <title>Materials and methods</title>
      <p id="P11">The DNA samples used in this study were collected by the Dystonia Coalition (DC) and acquired from the Coriell Institute for Medical Research (Camden, New Jersey, United State). The DC is part of the Rare Diseases Clinical Research Network, which is funded by the National Institutes of Health and led by the National Center for Advancing Translational Sciences (NCATS). The DC is funded under a grant (U54NS116025) as a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke. DNA analyses were approved by the University of Memphis Institutional Review Board. The cohort reported herein consisted of 307 subjects with BSP (<italic toggle="yes">N</italic> = 200) or BSP+ (<italic toggle="yes">N</italic> = 107) phenotypes. BSP+ phenotypes included subjects with BSP along with various combinations of lower facial, oromandibular and cervical dystonia. There were 224 females and 83 males with ages of acquisition ranging from 19 to 87 years. The median age at acquisition was 63 years with a mean &#xB1; standard deviation of 63.1 &#xB1; 11.0 years. Self-declared races included 259 whites, 1 Native American, 1 Pacific Islander, 11 Asians, 20 African Americans, 5 multi-racial, and 10 of other, not reported, or unknown race.</p>
      <p id="P12">Genome assembly GRCh38.p14 served as the reference for primer design and variant annotation. Primers were designed to cover the coding regions of <italic toggle="yes">REEP4</italic> along with exon-intron boundaries (<xref rid="SD1" ref-type="supplementary-material">Supplementary Table S1</xref>). Sequencing also extended into proximal intergenic regions 5&#x2032; and 3&#x2032; to <italic toggle="yes">REEP4.</italic> Unidirectional Sanger sequencing was completed in the entire cohort of 307 subjects with BSP and BSP+ phenotypes. Bidirectional Sanger sequencing was used to confirm all identified variants.</p>
      <p id="P13">ClinVar [<xref rid="R24" ref-type="bibr">24</xref>] and PubMed were analyzed for reported and published <italic toggle="yes">REEP4</italic> variants up to 15 July 2023. PubMed was interrogated with the search terms dystonia, blepharospasm, gene, genetics, mutation, genetic variant, Meige, and <italic toggle="yes">REEP4</italic>. The gnomAD V3.1.2 database was used to assess the frequency of these variants in a larger population [<xref rid="R25" ref-type="bibr">25</xref>, <xref rid="R26" ref-type="bibr">26</xref>]. The v3.1.2 data set includes 76,156 whole genomes mapped to GRCh38/hg38k<sup><xref rid="FN4" ref-type="fn">1</xref></sup>.</p>
      <p id="P14">CADD-Phred-scores [<xref rid="R27" ref-type="bibr">27</xref>, <xref rid="R28" ref-type="bibr">28</xref>], MetaLR [<xref rid="R29" ref-type="bibr">29</xref>], and REVEL [<xref rid="R30" ref-type="bibr">30</xref>] were used to access variant deleteriousness. A CADD-Phred score of 10 indicates that the variant is among the 10% most deleterious in the genome, a score of 20 indicates that the variant is among the 1% most deleterious variant in the genome, and so on. Pathogenicity classification followed the standards set by the American College of Medical Genetics and Genomics [<xref rid="R31" ref-type="bibr">31</xref>], considering factors such as population data, variant databases, co-segregation, disease databases, and location of the variant within established functional domains of the encoded protein. Variants were classified by suggested terminology: &#x201C;pathogenic,&#x201D; &#x201C;likely pathogenic,&#x201D; &#x201C;uncertain significance,&#x201D; &#x201C;likely benign,&#x201D; and &#x201C;benign.&#x201D; The gnomAD v3.1.2 data set was examined for putative loss-of-function (pLoF) variants.</p>
    </sec>
    <sec id="S7">
      <title>Results</title>
      <p id="P15">No highly deleterious variants were identified in our cohort of 307 subjects (<xref rid="T1" ref-type="table">Table 1</xref>). One variant (NM_025232.4: c.129T&gt;A, NP_079508.2:p.Ile43Ile) resulted in an Exon 3 synonymous change from Isoleucine (Ile) to Isoleucine (Ile). Although mildly deleterious (CADD = 9.78), the c.129T&gt;A variant was present in a higher percentage (7.7%) of gnomAD v3.1.2 alleles (z = &#x2212;4.89, <italic toggle="yes">p &lt;</italic> 0.0001). This variant is located within a ZNF263 binding site [<xref rid="R32" ref-type="bibr">32</xref>] (OREG1946722) and could play a role in gene expression. Five of the identified variants were non-coding. In comparison to our BSP/BSP+ cohort, all these variants were present in a higher percentage of gnomAD v3.1.2 alleles.</p>
      <p id="P16">On 28 July 2023, ClinVar reported clinical significance for 93 variants (1 likely benign, 22 of uncertain significance, 4 likely pathogenic, and 66 pathogenic). Of the 66 pathogenic variants, 57 were duplications and 7 were deletions, all large structural variants affecting more than one gene. Of the 16 single nucleotide variants (SNVs), 1 was likely benign and 15 were of uncertain significance (<xref rid="T2" ref-type="table">Table 2</xref>). All SNVs were associated with an &#x201C;inborn genetic disease&#x201D; and deposited by a single submitter. Thirteen of these SNVs are highly deleterious to protein function with CADD scores &gt;20 (<xref rid="T2" ref-type="table">Table 2</xref>). The variants are distributed across the encoded REEP4 from amino acid (aa) residues 16 to 226 (REEP4 Isoform 1 = 257 aa).</p>
      <p id="P17">Three <italic toggle="yes">REEP4</italic> screening studies have been published to date. Hammer and colleagues [<xref rid="R18" ref-type="bibr">18</xref>] examined 132 patients (116 white) diagnosed with BSP or BSP+ phenotypes. A second study included 78 Han Chinese [<xref rid="R19" ref-type="bibr">19</xref>] and a third study from Hungary screened 47 nonrelated patients with BSP and 74 patients with cervical dystonia [<xref rid="R32" ref-type="bibr">32</xref>]. A total of 70 patients harbored a <italic toggle="yes">REEP4</italic> variant. A total of 19 variants were reported in the literature. The most common (<italic toggle="yes">N</italic> =27) was the synonymous variant (p.Ile43Ile) in Exon 3. Seven published variants included in <xref rid="T2" ref-type="table">Table 2</xref> have CADD-Phred scores &gt;20.0 but 3/7 have population prevalence rates above 0.01% (&gt;1/10,000). We classified 10 of the 19 published variants as benign due to CADD-Phred scores &lt;10 and high population prevalence rates. The p.Arg37Trp variant [<xref rid="R17" ref-type="bibr">17</xref>] was classified as likely pathogenic due to positive co-segregation in a large pedigree, CADD-Phred score &gt;30, high REVEL and MetaLR scores, and low population prevalence. The other 8 variants were classified as &#x201C;uncertain significance.&#x201D;</p>
      <p id="P18">A total of 11 unique unflagged pLoF <italic toggle="yes">REEP4</italic> variants is reported in 12 individuals within the gnomAD v3.1.2 database. Nine of these variants are in coding regions of <italic toggle="yes">REEP4</italic> (7 frameshift, 2 stop gained), and two are splice acceptors. CADD-Phred scores for these pLoF variants range from 25.7 to 45.0 with a mean of 31.9. The gnomAD v3.1.2 database does not provide Loss Intolerance probability (pLI). For the gnomAD v2.1.1 database, the pLI score for <italic toggle="yes">REEP4</italic> is 0.03.</p>
    </sec>
    <sec id="S8">
      <title>Discussion</title>
      <p id="P19">Without comprehensive co-segregation analyses in pedigrees with dystonia and trio analyses in early-onset neurological disorders, it is not possible to convincingly ascribe pathogenicity to published and reported <italic toggle="yes">REEP4</italic> variants. Moreover, the study of dystonia genetics is compromised by subtle phenotypes, incomplete penetrance, possible pleiotropy, and the largely unexplored possibilities of recessive and oligogenic inheritance patterns. Assuming penetrance of 20% for a BSP-associated gene and BSP population prevalence of 50&#x2013;100 cases per million [<xref rid="R34" ref-type="bibr">34</xref>], a possibly pathogenic variant should be seen in no more than 20/100,000 alleles. The variants tabulated herein that exceeded that threshold are unlikely to be causal in monogenic fashion.</p>
      <p id="P20">In addition to lack of co-segregation analyses (e.g., phenotyping and genotyping all available family members) there are other obvious limitations to our screening study. First, Sanger sequencing will often miss exonic deletions and large structural variants. Second, our study was limited to BSP as driven by our previous identification of REEP4 p.Arg37Trp in an African-American family. It is possible that REEP4 plays a more important role in other forms of focal dystonia or spastic paraplegia. In this regard, a novel variant in <italic toggle="yes">ATP5MC3</italic> co-segregated with both dystonia and spastic paraplegia in a large multiplex pedigree [<xref rid="R35" ref-type="bibr">35</xref>]. Third, we have not characterized the biological effects of individual variants using cellular, invertebrate, or vertebrate model systems. <italic toggle="yes">In silico</italic> assessments of deleteriousness are informative but, in isolation, cannot establish causality.</p>
      <p id="P21">The REEP family of REEP1&#x2013;6 can be divided into subfamilies REEP1&#x2013;4 and REEP5&#x2013;6. The REEP1&#x2013;4 subfamily can be separated into REEP1&#x2013;2 and REEP3&#x2013;4 groups based on structural/functional similarities [<xref rid="R36" ref-type="bibr">36</xref>]. While REEP1 and REEP2 are linked to HSP, REEP6 is associated with retinitis pigmentosa 77 [<xref rid="R37" ref-type="bibr">37</xref>]. REEP3 and REEP5 have not yet been associated with specific neuro-ophthalmological or general medical disorders. REEP4 protein is expressed in regions of the brain (basal ganglia and cerebellum) that play a role in the pathophysiology of dystonia<sup><xref rid="FN5" ref-type="fn">2</xref></sup>, and very few pLoF variants are included in the gnomAD v3.1.2 database. This information suggests a possible role for REEP4 in neuro-ophthalmological disorders. In this regard, the gnomAD v2.1.1 pLI score for single nucleotide variants must be recognized but interpreted with caution [<xref rid="R38" ref-type="bibr">38</xref>].</p>
      <p id="P22">Several non-coding intronic and nearby intergenic <italic toggle="yes">REEP4</italic> variants were identified in our screening study but all of these were present at higher frequency in the gnomAD v.3.1.2 database. These differences in allele frequency are likely due to population stratification since the majority of Coriell DC samples were likely collected from only a few high enrolling sites whereas the gnomAD v.3.1.2 data was derived from more geographically diverse populations. One or more of these variants in isolation or a combination of variants (haplotype) could, in theory, play a role in <italic toggle="yes">REEP4</italic> expression. For instance, the intergenic variant NC_000008.11:g.22137633C&gt;G is located within a regulatory region (OREG0018606) [<xref rid="R39" ref-type="bibr">39</xref>], binding site for transcription factors TFAP2C (OREG1194750), FOXP1 (OREG1608060), and CTCF (OREG1385204), and distal enhancer-like signature (dELS, EH38E2616119) [<xref rid="R40" ref-type="bibr">40</xref>].</p>
      <p id="P23">In conclusion, more work is required to establish a convincing role for <italic toggle="yes">REEP4</italic> in dystonia and other neurological disorders. Of note, <italic toggle="yes">REEP4</italic> may make a more significant contribution to African American dystonia, whereas our work herein and other published screening studies of <italic toggle="yes">REEP4</italic> were focused on white Americans, Chinese, and Hungarians. Future studies should include patients with other forms of dystonia, more diverse racial and ethnic populations, and include phenotypic and genotypic assessments of other family members. Family studies with trio analyses are essential for understanding early-onset neurological disorders. Finally, inclusion of <italic toggle="yes">REEP4</italic> in commercial dystonia DNA panels would be of clear value to the scientific community.</p>
    </sec>
    <sec sec-type="supplementary-material" id="SM1">
      <title>Supplementary Material</title>
      <supplementary-material id="SD1" position="float" content-type="local-data">
        <label>Supplementary Material</label>
        <media xlink:href="NIHMS1982898-supplement-Supplementary_Material.pdf" id="d67e462" position="anchor"/>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack id="S9">
      <title>Funding</title>
      <p id="P24">ML was funded by the National Institutes of Health (R21NS123827 and R56NS123059), Department of Defense, Dystonia Medical Research Foundation, and Benign Essential Blepharospasm Research Foundation.</p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement" id="FN2">
        <p id="P26">Conflict of interest</p>
        <p id="P27">ML has been a consultant for USWorldMeds, Teva Pharmaceutical Industries, and Supernus; speaker for Teva Pharmaceutical Industries, USWorldMeds, Kyowa Kirin, and Acorda Therapeutics; and receives publishing royalties from Elsevier (Animal Models of Movement Disorders, and Movement Disorders: Genetics and Models) and TheBookPatch (Parkinson&#x2019;s Disease Poetry). ML&#x2019;s research has been funded by the Michael J. Fox Foundation, National Institutes of Health, Axovant Sciences, Wave Life Sciences, Teva Pharmaceutical Industries, Pharma Two B, Revance, Cerevel, Aeon, UCB Pharma, Inhibikinase Therapeutics, Scion, Neurocrine, Teva, Department of Defense, Dystonia Medical Research Foundation, and Benign Essential Blepharospasm Research Foundation.</p>
        <p id="P28">The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
      </fn>
      <fn id="FN3">
        <p id="P29">Ethics statement</p>
        <p id="P30">The studies involving humans were approved by the University of Memphis Institutional Review Board. The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from Coriell Institute. Written informed consent for participation was not required from the participants or the participants&#x2019; legal guardians/next of kin in accordance with national legislation and institutional requirements.</p>
      </fn>
      <fn id="FN4">
        <label>1</label>
        <p id="P31">
<ext-link xlink:href="https://gnomad.broadinstitute.org/stats" ext-link-type="uri">https://gnomad.broadinstitute.org/stats</ext-link>
</p>
      </fn>
      <fn id="FN5">
        <label>2</label>
        <p id="P32">
<ext-link xlink:href="http://proteinatlas.org" ext-link-type="uri">proteinatlas.org</ext-link>
</p>
      </fn>
      <fn id="FN6">
        <p id="P33">Supplementary material</p>
        <p id="P34">The Supplementary Material for this article can be found online at: <ext-link xlink:href="https://www.frontierspartnerships.org/articles/10.3389/dyst.2024.12016/full#supplementary-material" ext-link-type="uri">https://www.frontierspartnerships.org/articles/10.3389/dyst.2024.12016/full#supplementary-material</ext-link>.</p>
      </fn>
    </fn-group>
    <sec sec-type="data-availability" id="S10">
      <title>Data availability statement</title>
      <p id="P25">The original contributions presented in the study are included in the article/<xref rid="SD1" ref-type="supplementary-material">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><name><surname>Defazio</surname><given-names>G</given-names></name>, <name><surname>Hallett</surname><given-names>M</given-names></name>, <name><surname>Jinnah</surname><given-names>HA</given-names></name>, <name><surname>Berardelli</surname><given-names>A</given-names></name>. <article-title>Development and validation of a clinical guideline for diagnosing blepharospasm</article-title>. <source>Neurology</source> (<year>2013</year>) <volume>81</volume>(<issue>3</issue>):<fpage>236</fpage>&#x2013;<lpage>40</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e31829bfdf6</pub-id><pub-id pub-id-type="pmid">23771487</pub-id>
</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><name><surname>LeDoux</surname><given-names>MS</given-names></name>. <article-title>Meige syndrome: what&#x2019;s in a name?</article-title>
<source>Parkinsonism Relat Disord</source> (<year>2009</year>) <volume>15</volume>(<issue>7</issue>):<fpage>483</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.parkreldis.2009.04.006</pub-id><pub-id pub-id-type="pmid">19457699</pub-id>
</mixed-citation>
      </ref>
      <ref id="R3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><name><surname>Scorr</surname><given-names>LM</given-names></name>, <name><surname>Cho</surname><given-names>HJ</given-names></name>, <name><surname>Kilic-Berkmen</surname><given-names>G</given-names></name>, <name><surname>McKay</surname><given-names>JL</given-names></name>, <name><surname>Hallett</surname><given-names>M</given-names></name>, <name><surname>Klein</surname><given-names>C</given-names></name>, <etal/>
<article-title>Clinical features and evolution of blepharospasm: a multicenter international cohort and systematic literature review</article-title>. <source>Dystonia</source> (<year>2022</year>) <volume>1</volume>:<fpage>10359</fpage>. doi:<pub-id pub-id-type="doi">10.3389/dyst.2022.10359</pub-id><pub-id pub-id-type="pmid">36248010</pub-id>
</mixed-citation>
      </ref>
      <ref id="R4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><name><surname>Waln</surname><given-names>O</given-names></name>, <name><surname>LeDoux</surname><given-names>MS</given-names></name>. <article-title>Blepharospasm plus cervical dystonia with predominant anterocollis: a distinctive subphenotype of segmental craniocervical dystonia</article-title>. <source>Tremor and Other Hyperkinetic Movements</source> (<year>2011</year>) <volume>1</volume>:<comment>tre-01&#x2013;33-140&#x2013;2.</comment> doi:<pub-id pub-id-type="doi">10.5334/tohm.77</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><name><surname>Duane</surname><given-names>DD</given-names></name>. <article-title>Spasmodic torticollis: clinical and biologic features and their implications for focal dystonia</article-title>. <source>Adv Neurol</source> (<year>1988</year>) <volume>50</volume>:<fpage>473</fpage>&#x2013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">3400504</pub-id>
</mixed-citation>
      </ref>
      <ref id="R6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><name><surname>Grandas</surname><given-names>F</given-names></name>, <name><surname>Elston</surname><given-names>J</given-names></name>, <name><surname>Quinn</surname><given-names>N</given-names></name>, <name><surname>Marsden</surname><given-names>CD</given-names></name>. <article-title>Blepharospasm: a review of 264 patients</article-title>. <source>J Neurol NeurosurgPsychiatry</source> (<year>1988</year>) <volume>51</volume>(<issue>6</issue>):<fpage>767</fpage>&#x2013;<lpage>72</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.51.6.767</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>J</given-names></name>, <name><surname>Brin</surname><given-names>MF</given-names></name>, <name><surname>Fahn</surname><given-names>S</given-names></name>. <article-title>Idiopathic cervical dystonia: clinical characteristics</article-title>.<source>Mov Disord official J Mov Disord Soc</source> (<year>1991</year>) <volume>6</volume>(<issue>2</issue>):<fpage>119</fpage>&#x2013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.870060206</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><name><surname>Defazio</surname><given-names>G</given-names></name>, <name><surname>Martino</surname><given-names>D</given-names></name>, <name><surname>Aniello</surname><given-names>MS</given-names></name>, <name><surname>Masi</surname><given-names>G</given-names></name>, <name><surname>Abbruzzese</surname><given-names>G</given-names></name>, <name><surname>Lamberti</surname><given-names>S</given-names></name>, <etal/>
<article-title>A family study on primary blepharospasm</article-title>. <source>J Neurol Neurosurg Psychiatry</source> (<year>2006</year>) <volume>77</volume>(<issue>2</issue>):<fpage>252</fpage>&#x2013;<lpage>4</lpage>. doi:<pub-id pub-id-type="doi">10.1136/jnnp.2005.068007</pub-id><pub-id pub-id-type="pmid">16421132</pub-id>
</mixed-citation>
      </ref>
      <ref id="R9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><name><surname>Defazio</surname><given-names>G</given-names></name>, <name><surname>Martino</surname><given-names>D</given-names></name>, <name><surname>Aniello</surname><given-names>MS</given-names></name>, <name><surname>Masi</surname><given-names>G</given-names></name>, <name><surname>Gigante</surname><given-names>A</given-names></name>, <name><surname>Bhatia</surname><given-names>K</given-names></name>, <etal/>
<article-title>Planning genetic studies on primary adult-onset dystonia: sample size estimates based on examination of first-degree relatives</article-title>. <source>J Neurol Sci</source> (<year>2006</year>) <volume>251</volume>(<issue>1&#x2013;2</issue>):<fpage>29</fpage>&#x2013;<lpage>34</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jns.2006.08.009</pub-id><pub-id pub-id-type="pmid">17078970</pub-id>
</mixed-citation>
      </ref>
      <ref id="R10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><name><surname>Bressman</surname><given-names>SB</given-names></name>, <name><surname>Sabatti</surname><given-names>C</given-names></name>, <name><surname>Raymond</surname><given-names>D</given-names></name>, <name><surname>de Leon</surname><given-names>D</given-names></name>, <name><surname>Klein</surname><given-names>C</given-names></name>, <name><surname>Kramer</surname><given-names>PL</given-names></name>, <etal/>
<article-title>The DYT1 phenotype and guidelines for diagnostic testing</article-title>. <source>Neurology</source> (<year>2000</year>) <volume>54</volume>(<issue>9</issue>):<fpage>1746</fpage>&#x2013;<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1212/wnl.54.9.1746</pub-id><pub-id pub-id-type="pmid">10802779</pub-id>
</mixed-citation>
      </ref>
      <ref id="R11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>J</given-names></name>, <name><surname>Uitti</surname><given-names>RJ</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Vemula</surname><given-names>SR</given-names></name>, <name><surname>Perlmutter</surname><given-names>JS</given-names></name>, <name><surname>Wszolek</surname><given-names>ZK</given-names></name>, <etal/>
<article-title>Mutations in CIZ1 cause adult onset primary cervical dystonia</article-title>. <source>Ann Neurol</source> (<year>2012</year>) <volume>71</volume>(<issue>4</issue>):<fpage>458</fpage>&#x2013;<lpage>69</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.23547</pub-id><pub-id pub-id-type="pmid">22447717</pub-id>
</mixed-citation>
      </ref>
      <ref id="R12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><name><surname>Vemula</surname><given-names>SR</given-names></name>, <name><surname>Xiao</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Bastian</surname><given-names>RW</given-names></name>, <name><surname>Perlmutter</surname><given-names>JS</given-names></name>, <name><surname>Racette</surname><given-names>BA</given-names></name>, <etal/>
<article-title>A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia</article-title>. <source>Mol Genet Genomic Med</source> (<year>2014</year>) <volume>2</volume>(<issue>3</issue>):<fpage>261</fpage>&#x2013;<lpage>72</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mgg3.67</pub-id><pub-id pub-id-type="pmid">24936516</pub-id>
</mixed-citation>
      </ref>
      <ref id="R13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><name><surname>Vemula</surname><given-names>SR</given-names></name>, <name><surname>Puschmann</surname><given-names>A</given-names></name>, <name><surname>Xiao</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Rudzinska</surname><given-names>M</given-names></name>, <name><surname>Frei</surname><given-names>KP</given-names></name>, <etal/>
<article-title>Role of Ga(olf) in familial and sporadic adult-onset primary dystonia</article-title>. <source>Hum Mol Genet</source> (<year>2013</year>) <volume>22</volume>(<issue>12</issue>):<fpage>2510</fpage>&#x2013;<lpage>9</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddt102</pub-id><pub-id pub-id-type="pmid">23449625</pub-id>
</mixed-citation>
      </ref>
      <ref id="R14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Bastian</surname><given-names>RW</given-names></name>, <name><surname>Perlmutter</surname><given-names>JS</given-names></name>, <name><surname>Racette</surname><given-names>BA</given-names></name>, <name><surname>Tabbal</surname><given-names>SD</given-names></name>, <etal/>
<article-title>The c.&#x2212;237_236GA&gt;TT THAP1 sequence variant does not increase risk for primary dystonia</article-title>. <source>Mov Disord official J Mov Disord Soc</source> (<year>2011</year>) <volume>26</volume>(<issue>3</issue>):<fpage>549</fpage>&#x2013;<lpage>52</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.23551</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>J</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Bastian</surname><given-names>RW</given-names></name>, <name><surname>Perlmutter</surname><given-names>JS</given-names></name>, <name><surname>Racette</surname><given-names>BA</given-names></name>, <name><surname>Tabbal</surname><given-names>SD</given-names></name>, <etal/>
<article-title>Novel THAP1 sequence variants in primary dystonia</article-title>. <source>Neurology</source> (<year>2010</year>) <volume>74</volume>(<issue>3</issue>):<fpage>229</fpage>&#x2013;<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.1212/WNL.0b013e3181ca00ca</pub-id><pub-id pub-id-type="pmid">20083799</pub-id>
</mixed-citation>
      </ref>
      <ref id="R16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><name><surname>LeDoux</surname><given-names>MS</given-names></name>, <name><surname>Xiao</surname><given-names>J</given-names></name>, <name><surname>Rudzinska</surname><given-names>M</given-names></name>, <name><surname>Bastian</surname><given-names>RW</given-names></name>, <name><surname>Wszolek</surname><given-names>ZK</given-names></name>, <name><surname>Van Gerpen</surname><given-names>JA</given-names></name>, <etal/>
<article-title>Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2012</year>) <volume>18</volume>(<issue>5</issue>):<fpage>414</fpage>&#x2013;<lpage>25</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.parkreldis.2012.02.001</pub-id><pub-id pub-id-type="pmid">22377579</pub-id>
</mixed-citation>
      </ref>
      <ref id="R17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><name><surname>Tian</surname><given-names>J</given-names></name>, <name><surname>Vemula</surname><given-names>SR</given-names></name>, <name><surname>Xiao</surname><given-names>J</given-names></name>, <name><surname>Valente</surname><given-names>EM</given-names></name>, <name><surname>Defazio</surname><given-names>G</given-names></name>, <name><surname>Petrucci</surname><given-names>S</given-names></name>, <etal/>
<article-title>Whole-exome sequencing for variant discovery in blepharospasm</article-title>. <source>Mol Genet Genomic Med</source> (<year>2018</year>) <volume>6</volume>(<issue>4</issue>):<fpage>601</fpage>&#x2013;<lpage>26</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mgg3.411</pub-id><pub-id pub-id-type="pmid">29770609</pub-id>
</mixed-citation>
      </ref>
      <ref id="R18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><name><surname>Hammer</surname><given-names>M</given-names></name>, <name><surname>Abravanel</surname><given-names>A</given-names></name>, <name><surname>Peckham</surname><given-names>E</given-names></name>, <name><surname>Mahloogi</surname><given-names>A</given-names></name>, <name><surname>Majounie</surname><given-names>E</given-names></name>, <name><surname>Hallett</surname><given-names>M</given-names></name>, <etal/>
<article-title>Blepharospasm: a genetic screening study in 132 patients</article-title>. <source>Parkinsonism Relat Disord</source> (<year>2019</year>) <volume>64</volume>:<fpage>315</fpage>&#x2013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.parkreldis.2019.04.003</pub-id><pub-id pub-id-type="pmid">30956059</pub-id>
</mixed-citation>
      </ref>
      <ref id="R19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><name><surname>Teng</surname><given-names>X</given-names></name>, <name><surname>Qu</surname><given-names>Q</given-names></name>, <name><surname>Shu</surname><given-names>Y</given-names></name>, <name><surname>Gong</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>B</given-names></name>, <name><surname>Qu</surname><given-names>J</given-names></name>. <article-title>Genetic screening in patients of meige syndrome and blepharospasm</article-title>. <source>Neurol Sci</source> (<year>2022</year>) <volume>43</volume>(<issue>6</issue>):<fpage>3683</fpage>&#x2013;<lpage>94</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10072-022-05900-8</pub-id><pub-id pub-id-type="pmid">35044558</pub-id>
</mixed-citation>
      </ref>
      <ref id="R20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><name><surname>Golchoubian</surname><given-names>B</given-names></name>, <name><surname>Brunner</surname><given-names>A</given-names></name>, <name><surname>Bragulat-Teixidor</surname><given-names>H</given-names></name>, <name><surname>Neuner</surname><given-names>A</given-names></name>, <name><surname>Akarlar</surname><given-names>BA</given-names></name>, <name><surname>Ozlu</surname><given-names>N</given-names></name>, <etal/>
<article-title>Reticulon-like REEP4 at the inner nuclear membrane promotes nuclear pore complex formation</article-title>. <source>J Cell Biol</source> (<year>2022</year>) <volume>221</volume>(<issue>2</issue>):<fpage>e202101049</fpage>. doi:<pub-id pub-id-type="doi">10.1083/jcb.202101049</pub-id><pub-id pub-id-type="pmid">34874453</pub-id>
</mixed-citation>
      </ref>
      <ref id="R21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><name><surname>Harrer</surname><given-names>P</given-names></name>, <name><surname>Schalk</surname><given-names>A</given-names></name>, <name><surname>Shimura</surname><given-names>M</given-names></name>, <name><surname>Baer</surname><given-names>S</given-names></name>, <name><surname>Calmels</surname><given-names>N</given-names></name>, <name><surname>Spitz</surname><given-names>MA</given-names></name>, <etal/>
<article-title>Recessive NUP54 variants underlie early-onset dystonia with striatal lesions</article-title>. <source>Ann Neurol</source> (<year>2023</year>) <volume>93</volume>(<issue>2</issue>):<fpage>330</fpage>&#x2013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1002/ana.26544</pub-id><pub-id pub-id-type="pmid">36333996</pub-id>
</mixed-citation>
      </ref>
      <ref id="R22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Phan</surname><given-names>S</given-names></name>, <name><surname>Shaw</surname><given-names>TR</given-names></name>, <name><surname>Ellisman</surname><given-names>MH</given-names></name>, <name><surname>Veatch</surname><given-names>SL</given-names></name>, <name><surname>Barmada</surname><given-names>SJ</given-names></name>, <etal/>
<article-title>TorsinA is essential for the timing and localization of neuronal nuclear pore complex biogenesis</article-title>. <source>bioRxiv</source> (<year>2023</year>).</mixed-citation>
      </ref>
      <ref id="R23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><name><surname>Fereshtehnejad</surname><given-names>SM</given-names></name>, <name><surname>Saleh</surname><given-names>PA</given-names></name>, <name><surname>Oliveira</surname><given-names>LM</given-names></name>, <name><surname>Patel</surname><given-names>N</given-names></name>, <name><surname>Bhowmick</surname><given-names>S</given-names></name>, <name><surname>Saranza</surname><given-names>G</given-names></name>, <etal/>
<article-title>Movement disorders in hereditary spastic paraplegia (HSP): a systematic review and individual participant data meta-analysis</article-title>. <source>Neurol Sci</source> (<year>2023</year>) <volume>44</volume>(<issue>3</issue>):<fpage>947</fpage>&#x2013;<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s10072-022-06516-8</pub-id><pub-id pub-id-type="pmid">36441344</pub-id>
</mixed-citation>
      </ref>
      <ref id="R24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><name><surname>Landrum</surname><given-names>MJ</given-names></name>, <name><surname>Lee</surname><given-names>JM</given-names></name>, <name><surname>Benson</surname><given-names>M</given-names></name>, <name><surname>Brown</surname><given-names>GR</given-names></name>, <name><surname>Chao</surname><given-names>C</given-names></name>, <name><surname>Chitipiralla</surname><given-names>S</given-names></name>, <etal/>
<article-title>ClinVar: improving access to variant interpretations and supporting evidence</article-title>. <source>Nucleic Acids Res</source> (<year>2018</year>) <volume>46</volume>(<issue>D1</issue>):<fpage>D1062</fpage>&#x2013;<lpage>D7</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkx1153</pub-id><pub-id pub-id-type="pmid">29165669</pub-id>
</mixed-citation>
      </ref>
      <ref id="R25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><name><surname>Lek</surname><given-names>M</given-names></name>, <name><surname>Karczewski</surname><given-names>KJ</given-names></name>, <name><surname>Minikel</surname><given-names>EV</given-names></name>, <name><surname>Samocha</surname><given-names>KE</given-names></name>, <name><surname>Banks</surname><given-names>E</given-names></name>, <name><surname>Fennell</surname><given-names>T</given-names></name>, <etal/>
<article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source> (<year>2016</year>) <volume>536</volume>(<issue>7616</issue>):<fpage>285</fpage>&#x2013;<lpage>91</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature19057</pub-id><pub-id pub-id-type="pmid">27535533</pub-id>
</mixed-citation>
      </ref>
      <ref id="R26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><collab>The 1000 Genomes Project Consortium</collab>. <article-title>A global reference for human genetic variation</article-title>. <source>Nature</source> (<year>2015</year>) <volume>526</volume>(<issue>7571</issue>):<fpage>68</fpage>&#x2013;<lpage>74</lpage>. doi:<pub-id pub-id-type="doi">10.1038/nature15393</pub-id><pub-id pub-id-type="pmid">26432245</pub-id>
</mixed-citation>
      </ref>
      <ref id="R27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><name><surname>Kircher</surname><given-names>M</given-names></name>, <name><surname>Witten</surname><given-names>DM</given-names></name>, <name><surname>Jain</surname><given-names>P</given-names></name>, <name><surname>O&#x2019;Roak</surname><given-names>BJ</given-names></name>, <name><surname>Cooper</surname><given-names>GM</given-names></name>, <name><surname>Shendure</surname><given-names>J</given-names></name>. <article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source>Nat Genet</source> (<year>2014</year>) <volume>46</volume>(<issue>3</issue>):<fpage>310</fpage>&#x2013;<lpage>5</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2892</pub-id><pub-id pub-id-type="pmid">24487276</pub-id>
</mixed-citation>
      </ref>
      <ref id="R28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><name><surname>Rentzsch</surname><given-names>P</given-names></name>, <name><surname>Witten</surname><given-names>D</given-names></name>, <name><surname>Cooper</surname><given-names>GM</given-names></name>, <name><surname>Shendure</surname><given-names>J</given-names></name>, <name><surname>Kircher</surname><given-names>M</given-names></name>. <article-title>CADD: predicting the deleteriousness of variants throughout the human genome</article-title>. <source>Nucleic Acids Res</source> (<year>2019</year>) <volume>47</volume>(<issue>D1</issue>):<fpage>D886</fpage>&#x2013;<lpage>D94</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gky1016</pub-id><pub-id pub-id-type="pmid">30371827</pub-id>
</mixed-citation>
      </ref>
      <ref id="R29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><name><surname>Dong</surname><given-names>C</given-names></name>, <name><surname>Wei</surname><given-names>P</given-names></name>, <name><surname>Jian</surname><given-names>X</given-names></name>, <name><surname>Gibbs</surname><given-names>R</given-names></name>, <name><surname>Boerwinkle</surname><given-names>E</given-names></name>, <name><surname>Wang</surname><given-names>K</given-names></name>, <etal/>
<article-title>Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies</article-title>. <source>Hum Mol Genet</source> (<year>2015</year>) <volume>24</volume>(<issue>8</issue>):<fpage>2125</fpage>&#x2013;<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddu733</pub-id><pub-id pub-id-type="pmid">25552646</pub-id>
</mixed-citation>
      </ref>
      <ref id="R30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><name><surname>Ioannidis</surname><given-names>NM</given-names></name>, <name><surname>Rothstein</surname><given-names>JH</given-names></name>, <name><surname>Pejaver</surname><given-names>V</given-names></name>, <name><surname>Middha</surname><given-names>S</given-names></name>, <name><surname>McDonnell</surname><given-names>SK</given-names></name>, <name><surname>Baheti</surname><given-names>S</given-names></name>, <etal/>
<article-title>REVEL: an ensemble method for predicting the pathogenicity of rare missense variants</article-title>. <source>Am J Hum Genet</source> (<year>2016</year>) <volume>99</volume>(<issue>4</issue>):<fpage>877</fpage>&#x2013;<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.08.016</pub-id><pub-id pub-id-type="pmid">27666373</pub-id>
</mixed-citation>
      </ref>
      <ref id="R31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><name><surname>Richards</surname><given-names>S</given-names></name>, <name><surname>Aziz</surname><given-names>N</given-names></name>, <name><surname>Bale</surname><given-names>S</given-names></name>, <name><surname>Bick</surname><given-names>D</given-names></name>, <name><surname>Das</surname><given-names>S</given-names></name>, <name><surname>Gastier-Foster</surname><given-names>J</given-names></name>, <etal/>
<article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology</article-title>. <source>Genet Med : official J Am Coll Med Genet</source> (<year>2015</year>) <volume>17</volume>(<issue>5</issue>):<fpage>405</fpage>&#x2013;<lpage>24</lpage>. doi:<pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id></mixed-citation>
      </ref>
      <ref id="R32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><name><surname>Salamon</surname><given-names>A</given-names></name>, <name><surname>Nagy</surname><given-names>ZF</given-names></name>, <name><surname>Pal</surname><given-names>M</given-names></name>, <name><surname>Szabo</surname><given-names>M</given-names></name>, <name><surname>Csosz</surname><given-names>A</given-names></name>, <name><surname>Szpisjak</surname><given-names>L</given-names></name>, <etal/>
<article-title>Genetic screening of a Hungarian cohort with focal dystonia identified several novel putative pathogenic gene variants</article-title>. <source>Int J Mol Sci</source> (<year>2023</year>) <volume>24</volume>(<issue>13</issue>):<fpage>10745</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijms241310745</pub-id><pub-id pub-id-type="pmid">37445923</pub-id>
</mixed-citation>
      </ref>
      <ref id="R33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><name><surname>Landrum</surname><given-names>MJ</given-names></name>, <name><surname>Chitipiralla</surname><given-names>S</given-names></name>, <name><surname>Brown</surname><given-names>GR</given-names></name>, <name><surname>Chen</surname><given-names>C</given-names></name>, <name><surname>Gu</surname><given-names>B</given-names></name>, <name><surname>Hart</surname><given-names>J</given-names></name>, <etal/>
<article-title>ClinVar: improvements to accessing data</article-title>. <source>Nucleic Acids Res</source> (<year>2020</year>) <volume>48</volume> (<issue>D1</issue>):<fpage>D835</fpage>&#x2013;<lpage>D844</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkz972</pub-id><pub-id pub-id-type="pmid">31777943</pub-id>
</mixed-citation>
      </ref>
      <ref id="R34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><name><surname>Defazio</surname><given-names>G</given-names></name>, <name><surname>Abbruzzese</surname><given-names>G</given-names></name>, <name><surname>Livrea</surname><given-names>P</given-names></name>, <name><surname>Berardelli</surname><given-names>A</given-names></name>. <article-title>Epidemiology of primary dystonia</article-title>. <source>Lancet Neurol</source> (<year>2004</year>) <volume>3</volume>(<issue>11</issue>):<fpage>673</fpage>&#x2013;<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(04)00907-X</pub-id><pub-id pub-id-type="pmid">15488460</pub-id>
</mixed-citation>
      </ref>
      <ref id="R35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><name><surname>Neilson</surname><given-names>DE</given-names></name>, <name><surname>Zech</surname><given-names>M</given-names></name>, <name><surname>Hufnagel</surname><given-names>RB</given-names></name>, <name><surname>Slone</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Homan</surname><given-names>S</given-names></name>, <etal/>
<article-title>A novel variant of ATP5MC3 associated with both dystonia and spastic paraplegia</article-title>. <source>Mov Disord official J Mov Disord Soc</source> (<year>2022</year>) <volume>37</volume>(<issue>2</issue>):<fpage>375</fpage>&#x2013;<lpage>83</lpage>. doi:<pub-id pub-id-type="doi">10.1002/mds.28821</pub-id></mixed-citation>
      </ref>
      <ref id="R36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><name><surname>Fan</surname><given-names>S</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <name><surname>Li</surname><given-names>L</given-names></name>. <article-title>The REEP family of proteins: molecular targets and role in pathophysiology</article-title>. <source>Pharmacol Res</source> (<year>2022</year>) <volume>185</volume>:<fpage>106477</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.phrs.2022.106477</pub-id><pub-id pub-id-type="pmid">36191880</pub-id>
</mixed-citation>
      </ref>
      <ref id="R37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><name><surname>Arno</surname><given-names>G</given-names></name>, <name><surname>Agrawal</surname><given-names>SA</given-names></name>, <name><surname>Eblimit</surname><given-names>A</given-names></name>, <name><surname>Bellingham</surname><given-names>J</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <name><surname>Wang</surname><given-names>F</given-names></name>, <etal/>
<article-title>Mutations in REEP6 cause autosomal-recessive retinitis pigmentosa</article-title>. <source>Am J Hum Genet</source> (<year>2016</year>) <volume>99</volume>(<issue>6</issue>):<fpage>1305</fpage>&#x2013;<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.10.008</pub-id><pub-id pub-id-type="pmid">27889058</pub-id>
</mixed-citation>
      </ref>
      <ref id="R38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><name><surname>Ziegler</surname><given-names>A</given-names></name>, <name><surname>Colin</surname><given-names>E</given-names></name>, <name><surname>Goudenege</surname><given-names>D</given-names></name>, <name><surname>Bonneau</surname><given-names>D</given-names></name>. <article-title>A snapshot of some pLI score pitfalls</article-title>. <source>Hum Mutat</source> (<year>2019</year>) <volume>40</volume>(<issue>7</issue>):<fpage>839</fpage>&#x2013;<lpage>41</lpage>. doi:<pub-id pub-id-type="doi">10.1002/humu.23763</pub-id><pub-id pub-id-type="pmid">30977936</pub-id>
</mixed-citation>
      </ref>
      <ref id="R39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><name><surname>Lesurf</surname><given-names>R</given-names></name>, <name><surname>Cotto</surname><given-names>KC</given-names></name>, <name><surname>Wang</surname><given-names>G</given-names></name>, <name><surname>Griffith</surname><given-names>M</given-names></name>, <name><surname>Kasaian</surname><given-names>K</given-names></name>, <name><surname>Jones</surname><given-names>SJ</given-names></name>, <etal/>
<article-title>ORegAnno 3.0: a community-driven resource for curated regulatory annotation</article-title>. <source>Nucleic Acids Res</source> (<year>2016</year>) <volume>44</volume>(<issue>D1</issue>):<fpage>D126</fpage>&#x2013;<lpage>32</lpage>. doi:<pub-id pub-id-type="doi">10.1093/nar/gkv1203</pub-id><pub-id pub-id-type="pmid">26578589</pub-id>
</mixed-citation>
      </ref>
      <ref id="R40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><collab>The ENCODE Project Consortium</collab>, <name><surname>Moore</surname><given-names>JE</given-names></name>, <name><surname>Purcaro</surname><given-names>MJ</given-names></name>, <name><surname>Pratt</surname><given-names>HE</given-names></name>, <name><surname>Epstein</surname><given-names>CB</given-names></name>, <name><surname>Shoresh</surname><given-names>N</given-names></name>, <etal/>
<article-title>Expanded encyclopaedias of DNA elements in the human and mouse genomes</article-title>. <source>Nature</source> (<year>2020</year>) <volume>583</volume>(<issue>7818</issue>):<fpage>699</fpage>&#x2013;<lpage>710</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-020-2493-4</pub-id><pub-id pub-id-type="pmid">32728249</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <table-wrap position="float" id="T1" orientation="landscape">
      <label>TABLE 1</label>
      <caption>
        <p id="P35"><italic toggle="yes">REEP4</italic> (GRCh38/hg38, NC_000008.11, NM_025232.4) variants identified with Sanger sequencing.</p>
      </caption>
      <table frame="box" rules="all">
        <colgroup span="1">
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">Variant</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Number of subjects</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Allele count</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Homozygotes</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Protein</th>
            <th align="left" valign="top" rowspan="1" colspan="1">gnomAD v3.1.2 allele frequency</th>
            <th align="left" valign="top" rowspan="1" colspan="1">CADD Phred-scaled</th>
            <th align="left" valign="top" rowspan="1" colspan="1">Clinical significance</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">NM_025232.4:c.418-43A&gt;T (rs56401147)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">73/307 (24%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">98/614 (16.0%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">15</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA (intronic)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">34,782/152,086 (22.87%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.127</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">NC_000008.11:g.22137633C&gt;G (rs79472476)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7/307 (1.63%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7/614 (1.14%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA (downstream)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2,421/152,174 (1.59%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2.76</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">NC_000008.11:g.22137584G&gt;T (rs12676497)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">57/307 (11.07%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">62/614 (10.1%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA (downstream)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">29,058/151,988 (19.12%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.091</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">NM_025232.4:c.129T&gt;A (rs35574275)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">15/307 (4.89%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">15/614 (2.44%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NP_079508.2:p.Ile43Ile</td>
            <td align="left" valign="top" rowspan="1" colspan="1">11,722/152,116 (7.71%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9.78</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">NC_000008.11:g.22142150A&gt;C (rs76026658)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9/307 (2.93%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9/614 (1.47%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA (upstream)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5,989/152,200 (3.94%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">1.66</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">NM_025232.4:c.418&#x2013; 25C&gt;T (rs73549542)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7/307 (1.95%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">7/614 (1.14%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA (intronic)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4,029/152,238 (2.65%)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.036</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="TFN1">
          <p id="P36">NA, not applicable</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap position="float" id="T2" orientation="landscape">
      <label>TABLE 2</label>
      <caption>
        <p id="P37">REEP4 variants reported by NCBI&#x2019;s ClinVar and PubMed.</p>
      </caption>
      <table frame="box" rules="all">
        <colgroup span="1">
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
          <col align="left" valign="middle" span="1"/>
        </colgroup>
        <thead>
          <tr>
            <th align="center" valign="top" rowspan="1" colspan="1">Variant (accession)</th>
            <th align="center" valign="top" rowspan="1" colspan="1">Protein change</th>
            <th align="center" valign="top" rowspan="1" colspan="1">Condition (number of probands)</th>
            <th align="center" valign="top" rowspan="1" colspan="1">Clinical significance</th>
            <th align="center" valign="top" rowspan="1" colspan="1">gnomAD v3.1.2 (allele frequency)</th>
            <th align="center" valign="top" rowspan="1" colspan="1">CADD-Phred</th>
            <th align="center" valign="top" rowspan="1" colspan="1">MetaLR</th>
            <th align="center" valign="top" rowspan="1" colspan="1">REVEL</th>
            <th align="center" valign="top" rowspan="1" colspan="1">Reference</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.48G&gt;C (SCV003984452.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Met16Ile</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2/152,270</td>
            <td align="left" valign="top" rowspan="1" colspan="1">23.1</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.55</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.24</td>
            <td rowspan="16" align="left" valign="top" colspan="1">[<xref rid="R33" ref-type="bibr">33</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.101A&gt;T (SCV003692342.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Glu34Val</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">6/152,114</td>
            <td align="left" valign="top" rowspan="1" colspan="1">33.0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.93</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.94</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.116T&gt;C (SCV003757666.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Met39Thr</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">26.6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.87</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.91</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.118A&gt;T (SCV003678640.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Met40Leu</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5/152,096</td>
            <td align="left" valign="top" rowspan="1" colspan="1">29.0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.84</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.82</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.160G&gt;A (SCV003750691.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Val54Ile</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Likely benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.04</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.35</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.19</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.250G&gt;A (SCV003734663.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Ala84Thr</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">12/152,152</td>
            <td align="left" valign="top" rowspan="1" colspan="1">24.1</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.85</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.69</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.371G&gt;A (SCV003558622.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Arg124Gln</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">6/152,226</td>
            <td align="left" valign="top" rowspan="1" colspan="1">23.6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.42</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.41</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.382A&gt;G (SCV003620006.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Ile128Val</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">17.9</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.45</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.19</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.436G&gt;A (SCV003759714.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Gly146Ser</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">29/152,214</td>
            <td align="left" valign="top" rowspan="1" colspan="1">23.6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.54</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.30</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.436G&gt;T (SCV003974326.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Gly146Cys</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">26.4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.75</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.53</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.473C&gt;T (SCV003900529.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Ser158Phe</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">1/152,242</td>
            <td align="left" valign="top" rowspan="1" colspan="1">22.5</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.60</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.25</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.475A&gt;T (SCV003730928.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Ile159Phe</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">27/152,196</td>
            <td align="left" valign="top" rowspan="1" colspan="1">22.6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.56</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.32</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.583G&gt;A (SCV003888930.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Asp195Asn</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">22/152,192</td>
            <td align="left" valign="top" rowspan="1" colspan="1">21.7</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.33</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.19</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.634G&gt;C (SCV003759638.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Ala212Pro</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">5.3</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.33</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.11</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.662G&gt;A (SCV004002432.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Arg221His</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">14/152,208</td>
            <td align="left" valign="top" rowspan="1" colspan="1">23.4</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.59</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.49</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.676C&gt;T (SCV003893236.1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Arg226Cys</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Inborn genetic disease (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">1/152,226</td>
            <td align="left" valign="top" rowspan="1" colspan="1">27.0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.61</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.59</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.109C&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Arg37Trp</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP/BSP+ (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Likely pathogenic</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3/152,168</td>
            <td align="left" valign="top" rowspan="1" colspan="1">31.0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.960</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.77</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R17" ref-type="bibr">17</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.-404_-401delAAGT (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 3)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">96/152,274</td>
            <td align="left" valign="top" rowspan="1" colspan="1">21.1</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.129T&gt;A (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Ile43Ile</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 4 + 23 = 27)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">11,722/152,116</td>
            <td align="left" valign="top" rowspan="1" colspan="1">9.78</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>, <xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.303 + 137G&gt;C (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 5)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">54/152,204</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3.15</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.304-8G&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 2)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">124/152,174</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.025</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.446G&gt;A (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Arg149Gln</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 3)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">501/152,226</td>
            <td align="left" valign="top" rowspan="1" colspan="1">29.6</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.4856</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.73</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.418-43A&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 6)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">34,782/152,086</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.13</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.*170_*188del (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 8)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">18,507/152,046</td>
            <td align="left" valign="top" rowspan="1" colspan="1">8.51</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.649C&gt;T (NM_001316964.2)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Arg217Cys</td>
            <td rowspan="2" align="left" valign="top" colspan="1">BSP (<italic toggle="yes">N</italic> = 3)</td>
            <td rowspan="2" align="left" valign="top" colspan="1">Uncertain significance</td>
            <td rowspan="2" align="left" valign="top" colspan="1">1/152,226</td>
            <td rowspan="2" align="left" valign="top" colspan="1">9.34</td>
            <td rowspan="2" align="left" valign="top" colspan="1">0.66</td>
            <td rowspan="2" align="left" valign="top" colspan="1">0.20</td>
            <td rowspan="2" align="left" valign="top" colspan="1">[<xref rid="R19" ref-type="bibr">19</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.*39C&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.182 + 17C&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 2)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">174/152,206</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.22</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.312C&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Asp104Asp</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">738/152,206</td>
            <td align="left" valign="top" rowspan="1" colspan="1">1.18</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.418-12T&gt;C (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2.00</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.538C&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Arg180Trp</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">8/152,232</td>
            <td align="left" valign="top" rowspan="1" colspan="1">20.2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.3472</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.34</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.539G&gt;A (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Arg180Gln</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2,415/152,220</td>
            <td align="left" valign="top" rowspan="1" colspan="1">4.28</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.2425</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.16</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.553 + 28T&gt;C (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Benign</td>
            <td align="left" valign="top" rowspan="1" colspan="1">2,427/152,206</td>
            <td align="left" valign="top" rowspan="1" colspan="1">3.95</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.661C&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p. Arg221Cys</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (3 subjects) (<italic toggle="yes">N</italic> =3)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">703/152,212</td>
            <td align="left" valign="top" rowspan="1" colspan="1">24.0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.4778</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.33</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.*95_*96insTCCACGTCTGTG (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Val251_Pro252insSerThrSerVal</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">195/152,226</td>
            <td align="left" valign="top" rowspan="1" colspan="1">17.0</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">NA</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R18" ref-type="bibr">18</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.538C&gt;T (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Arg180Trp</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Cervical dystonia (<italic toggle="yes">N</italic> =1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">8/152,232</td>
            <td align="left" valign="top" rowspan="1" colspan="1">20.2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.44</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.34</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R32" ref-type="bibr">32</xref>]</td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">c.734G&gt;A (NM_025232.4)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">p.Arg245Gln</td>
            <td align="left" valign="top" rowspan="1" colspan="1">BSP (<italic toggle="yes">N</italic> = 1)</td>
            <td align="left" valign="top" rowspan="1" colspan="1">Uncertain significance</td>
            <td align="left" valign="top" rowspan="1" colspan="1">30/152,110</td>
            <td align="left" valign="top" rowspan="1" colspan="1">21.2</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.38</td>
            <td align="left" valign="top" rowspan="1" colspan="1">0.12</td>
            <td align="left" valign="top" rowspan="1" colspan="1">[<xref rid="R32" ref-type="bibr">32</xref>]</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="TFN2">
          <p id="P38">NA, not applicable.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>